Abstract
BackgroundLower vitamin D levels are found in people with schizophrenia and depressive disorders, and also associated with neuroimaging abnormalities such as reduced brain volume in both animals and humans. Reduced whole brain and increased ventricular volume are also systematically reported in schizophrenia. Even though vitamin D deficiency has been proposed as a risk mechanism for schizophrenia there exist no studies to date of the association between vitamin D levels and brain volume in this population. Therefore, we investigated the relationship between vitamin D levels and brain phenotypes in psychotic disorders, and assessed possible interactions with genetic variants in vitamin D receptor (VDR) and other genetic variants that play a role in vitamin D levels in the body.MethodsOur sample consisted of 83 psychosis patients and 101 healthy controls. We measured vitamin D levels as serum 25-hydroxyvitamin D. All participants were genotyped and neuroimaging conducted by structural magnetic resonance imaging.ResultsVitamin D levels were significantly positively associated with peripheral grey matter volume in patients (β 860.6; 95% confidence interval (CI) 333.4–1466, p < .003). A significant interaction effect of BSML marker (rs1544410) was observed to mediate the association between patient status and both white matter volume (β 23603.3; 95% CI 2732.8–48708.6, p < .05) and whole brain volume (β 46670.6, 95% CI 8817.8–93888.3, p < .04). Vitamin D did not predict ventricular volume, which rather was associated with patient status (β 4423.3, 95% CI 1583.2–7267.8p < .002) and CYP24A1 marker (rs6013897) (β 2491.5, 95% CI 269.7–4978.5, p < .04).ConclusionsThis is the first study of the association between vitamin D levels and brain volume in patients with psychotic disorders that takes into account possible interaction with genetic polymorphisms. The present findings warrant replication in independent samples.
Highlights
In the last decade, we have seen a growing interest in the possible interaction between vitamin D deficiency and the development or clinical expression of psychiatric disorders, in particular depression and schizophrenia
Vitamin D levels were significantly positively associated with peripheral grey matter volume in patients (β 860.6; 95% confidence interval (CI) 333.4–1466, p < .003)
Neither had any role in study design, data collection, analysis and interpretation, writing of the report, or the decision to submit the paper for publication
Summary
We have seen a growing interest in the possible interaction between vitamin D deficiency and the development or clinical expression of psychiatric disorders, in particular depression and schizophrenia. To further investigate the role of vitamin D in the etiology of psychosis, this study aims to demonstrate whether serum 25-hydroxyvitamin D (S-25(OH)D) levels and genetic variants that interact with vitamin D levels are related to altered global brain volumes previously implicated in psychotic disorders. Adults with schizophrenia and depression have been found to have lower serum 25-hyroxyvitamin D (S-25(OH)D) levels compared to healthy controls [4,5,6], which is the most stable measure of vitamin D from both dietary and environmental sources [7]. Lower vitamin D levels are found in people with schizophrenia and depressive disorders, and associated with neuroimaging abnormalities such as reduced brain volume in both animals and humans. We investigated the relationship between vitamin D levels and brain phenotypes in psychotic disorders, and assessed possible interactions with genetic variants in vitamin D receptor (VDR) and other genetic variants that play a role in vitamin D levels in the body
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
